Endologix
27
1
3
21
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
3.7%
1 terminated/withdrawn out of 27 trials
95.5%
+8.9% vs industry average
0%
0 trials in Phase 3/4
67%
14 of 21 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (27)
The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study
Role: lead
Nellix Registry Study: EVAS-Global
Role: lead
DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass
Role: lead
EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study
Role: lead
The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System
Role: lead
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
Role: lead
Nellix® Registry Study: EVAS-Global
Role: lead
Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication
Role: lead
TORUS I Clinical Study
Role: lead
JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Role: lead
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Role: lead
The DETOUR 2 Clinical Trial
Role: lead
Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
Role: lead
Detour2 Continued Access Study
Role: lead
Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices
Role: lead
PQ Bypass Guide Wire Delivery System for Femoropopliteal Bypass
Role: lead
Pilot Study of the Endologix Fenestrated Stent Graft System
Role: lead
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Role: lead
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft Investigational Device Exemption (IDE) Study
Role: lead
Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm
Role: lead